Botulinum toxin in the management of blepharospasm.

Published

Journal Article

Seventy-seven patients with blepharospasm unresponsive to other forms of therapy were treated with botulinum A toxin. The drug was injected into the orbicularis oculi muscle of both upper and lower eyelids and, in some patients, into the brows and upper part of the face as well. A total of 192 treatment sessions were given, with follow-up ranging from four weeks to 18 months. Orbicularis muscle spasms decreased markedly over the first five days following injection, both in patients with essential blepharospasm and in those with hemifacial spasm. Beneficial effect was temporary, however, and repeated injections were required for sustained relief. Fifty-two patients received multiple treatments, ranging from two to eight injections each, with a mean duration of benefit of 11.8 weeks. Results of subsequent injections were similar to the first in rapidity of onset, degree of benefit, and duration of effect. Complications were local, mild, and transient, and no systemic side effects were encountered.

Full Text

Duke Authors

Cited Authors

  • Dutton, JJ; Buckley, EG

Published Date

  • April 1986

Published In

Volume / Issue

  • 43 / 4

Start / End Page

  • 380 - 382

PubMed ID

  • 3954621

Pubmed Central ID

  • 3954621

International Standard Serial Number (ISSN)

  • 0003-9942

Digital Object Identifier (DOI)

  • 10.1001/archneur.1986.00520040060020

Language

  • eng

Conference Location

  • United States